Search results
Will Coca-Cola's Emerging Market Expansion Offset U.S. Slowdown?
The Coca-Cola Company’s KO long-term growth story increasingly hinges on its ability to capitalize on high-growth emerging markets while navigating a more mature and value-conscious U.S. market
Should Investors Buy WIX as Low Valuation Meets AI Spending Risks?
Wix.com Ltd. WIX combines double-digit growth with a forward-sales valuation below its historical norm. Base44, Harmony and a smaller share count strengthen the long-term case.
The trade-off is
3 Advertising & Marketing Stocks to Watch Amid Industry Woes
Earnings Estimates Rising for Life Time Group Holdings (LTH): Will It Gain?
Investors might want to bet on Life Time Group Holdings, Inc. (LTH), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term
Digital Turbine's AI Platform Boosts Advertiser Returns & Growth
Digital Turbine APPS is strengthening its competitive position through the artificial intelligence ("AI")-driven advertising platform, enabling advertisers to achieve higher returns on ad spend
Gilat Q2 Earnings Call Highlights Defense and IFC Momentum
Gilat Satellite Networks Ltd. GILT used its second-quarter 2026 earnings call to emphasize a stronger second half for Defense, in-flight connectivity expansion and the Comtech transaction.
In
Can HireQuest (HQI) Keep the Earnings Surprise Streak Alive?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider HireQuest
Zoetis Q2 Earnings Beat Estimates, Revenues Miss, 2026 View Cut
Zoetis, Inc. ZTS delivered second-quarter 2026 adjusted earnings (excluding one-time items) of $1.87 per share, which beat the Zacks Consensus Estimate of $1.84. In the year-ago quarter, the company
Fiserv Q2 Earnings Call Highlights
Key Points
- Interested in Fiserv, Inc.? Here are five stocks we like better.
- Fiserv lowered its full-year outlook, now expecting organic revenue growth of negative 1% to flat, adjusted revenue to
Dole's Q2 Earnings Upcoming: Here's What Lies Ahead for the Stock
Dole plc DOLE is slated to report second-quarter 2026 results on Aug. 10, before market open. The company is likely to report a top-line increase when it posts the quarterly results.For revenues
HUBS Q2 Earnings Call Highlights AI Pivot and Budget Pressure
HubSpot, Inc. HUBS used its earnings call for the second quarter of 2026 to frame weaker customer acquisition and a softer near-term outlook as the result of an intentional AI transition and greater
Is Shell Stock a Buy as Cash Flow Surges but Risks Stay Elevated?
Shell plc SHEL delivered a sharp second-quarter recovery, with stronger earnings, substantial cash generation and a lower debt load. Its discounted valuation and continued shareholder distributions
Realty Income Q2 Earnings Call Raises 2026 Growth Targets
Realty Income Corporation O raised full-year AFFO and investment targets on its second-quarter 2026 earnings call, citing a broader pipeline and improved funding visibility.
President and CEO Sumit
Should Investors Hold on to Astera Labs Stock Post Q2 Earnings?
Astera Labs ALAB shares have lost 12% since it reported second-quarter 2026 results on Aug. 4, 2026. The company’s second-quarter earnings suffered from higher operating expenses due to continued
How Jacobs' AI Infrastructure Push Could Drive Its Next Growth Phase
Jacobs Solutions Inc. J is turning Artificial Intelligence infrastructure into a meaningful growth engine. Fiscal third-quarter results showed that the opportunity now extends beyond data centers
Genmab A/S Q2 Earnings Call Highlights
Key Points
- Interested in Genmab A/S Sponsored ADR? Here are five stocks we like better.
- Genmab raised its 2026 outlook, now forecasting revenue of DKK 4.3 billion–DKK 4.5 billion and operating
GoodRx Q2 Earnings Call Highlights
Key Points
- Interested in GoodRx Holdings, Inc.? Here are five stocks we like better.
- GoodRx raised its full-year outlook after reporting Q2 revenue of $200.4 million and adjusted EBITDA of $63.7
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics, Inc. ANGO offers investors a clear trade-off. Its Med Tech platforms are expanding quickly, but near-term earnings conversion remains weak as tariffs and operating costs absorb part
Micron & 2 Profitable Stocks Smart Investors Are Buying in August
Historically, August has been a volatile month for the stock market, but this year it has relatively begun on a steady note. Banking on this optimism, investors should focus on companies that



